Nu Skin Enterprises Inc. (NYSE:NUS) Director Andrew D. Lipman sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $64.13, for a total transaction of $1,923,900.00. Following the completion of the sale, the director now directly owns 36,090 shares in the company, valued at approximately $2,314,451.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Nu Skin Enterprises Inc. (NYSE:NUS) opened at 63.12 on Friday. Nu Skin Enterprises Inc. has a 52-week low of $23.51 and a 52-week high of $64.48. The stock has a market capitalization of $3.53 billion, a price-to-earnings ratio of 36.21 and a beta of 1.75. The company has a 50-day moving average of $59.04 and a 200-day moving average of $46.28.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, August 4th. The company reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.78 by $0.01. The firm earned $600.05 million during the quarter, compared to analysts’ expectations of $578.87 million. Nu Skin Enterprises had a return on equity of 18.46% and a net margin of 4.52%. Nu Skin Enterprises’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.75 EPS. Equities research analysts expect that Nu Skin Enterprises Inc. will post $2.88 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, September 14th. Shareholders of record on Friday, August 26th were issued a $0.355 dividend. This represents a $1.42 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio is presently 81.14%.
A number of institutional investors have recently added to or reduced their stakes in NUS. Sterling Capital Management LLC bought a new position in Nu Skin Enterprises during the second quarter worth $2,182,000. Amalgamated Bank boosted its position in Nu Skin Enterprises by 6.0% in the second quarter. Amalgamated Bank now owns 7,263 shares of the company’s stock worth $423,000 after buying an additional 414 shares in the last quarter. Legal & General Group Plc boosted its position in Nu Skin Enterprises by 33.0% in the second quarter. Legal & General Group Plc now owns 29,193 shares of the company’s stock worth $1,348,000 after buying an additional 7,246 shares in the last quarter. Metropolitan Life Insurance Co. NY raised its position in shares of Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares during the last quarter. Finally, AQR Capital Management LLC raised its position in shares of Nu Skin Enterprises by 15.0% in the second quarter. AQR Capital Management LLC now owns 1,079,144 shares of the company’s stock worth $49,845,000 after buying an additional 140,649 shares during the last quarter. Hedge funds and other institutional investors own 77.08% of the company’s stock.
NUS has been the topic of several analyst reports. Citigroup Inc. raised their target price on shares of Nu Skin Enterprises from $52.00 to $61.00 and gave the company a “buy” rating in a report on Friday, August 5th. Jefferies Group set a $46.00 price objective on shares of Nu Skin Enterprises and gave the stock a “hold” rating in a report on Monday, July 25th. Deutsche Bank AG reissued a “hold” rating and set a $55.00 price objective (up previously from $45.00) on shares of Nu Skin Enterprises in a report on Sunday, July 24th. Stifel Nicolaus raised their price objective on shares of Nu Skin Enterprises from $34.00 to $45.00 and gave the stock a “sell” rating in a report on Friday, August 5th. Finally, Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective on the stock in a report on Tuesday, June 21st. Two investment analysts have rated the stock with a sell rating, four have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Nu Skin Enterprises currently has an average rating of “Hold” and an average price target of $50.72.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.